Biogen BIIB
NASDAQ BIIB
$222.82 -3.06 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biogen (BIIB) Operating Expenses (2009 - 2026)

Updated

Biogen (BIIB) posted Operating Expenses of $2.6 billion for Q2 2026, up 36.9% from $1.9 billion a year earlier and up 24.0% from the prior quarter.

Analysis

Biogen (BIIB) Operating Expenses (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Biogen was $9.02 billion, up 10.0% year-over-year; for FY2025, it came in at $8.33 billion, up 7.3% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
  • In prior years, Biogen's Operating Expenses was $7.77 billion in FY2024 (-9.0%), $8.54 billion in FY2023 (+29.7%), $6.58 billion in FY2022 (-28.7%) and $9.24 billion in FY2021 (+10.0%).
  • The Q2 2026 figure stands as the highest quarterly Operating Expenses since Q3 2023.
  • On a year-over-year basis, Operating Expenses increased in five of the last eight quarters, with growth averaging 5.6%.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q3 2023, with growth of 134.9%; the weakest was Q3 2022, with a decline of 54.3%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $2.1 billion (Q1 2026), $2.34 billion (Q4 2025) and $1.98 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Biogen 33.37 Bn 20.03 Bn 1.96 Bn 2.60 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.60 Bn
Mar 31, 2026 2.10 Bn
Dec 31, 2025 2.34 Bn
Sep 30, 2025 1.98 Bn
Jun 30, 2025 1.90 Bn
Mar 31, 2025 2.12 Bn
Dec 31, 2024 2.16 Bn
Sep 30, 2024 2.01 Bn
Jun 30, 2024 1.77 Bn
Mar 31, 2024 1.83 Bn
Dec 31, 2023 2.09 Bn
Sep 30, 2023 2.67 Bn
Jun 30, 2023 1.75 Bn
Mar 31, 2023 2.02 Bn
Dec 31, 2022 1.94 Bn
Sep 30, 2022 1.14 Bn
Jun 30, 2022 1.32 Bn
Mar 31, 2022 2.18 Bn
Dec 31, 2021 2.33 Bn
Sep 30, 2021 2.49 Bn
API Access

Biogen Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=BIIB&period=max&api_key=YOUR_API_KEY